Curetis NV CUREProduct Pipeline Analysis, 2017 Update, Market Outlook: Ken Research
Curetis NV (CURE)-Product Pipeline Analysis, 2017 Update

Curetis NV (CURE)-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME59289PD
  • |
  • Pages: 51
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, implant and tissue infections; and in the laboratory for multiplex polymerase chain reaction pcr diagnostics. It caters to biotechnology, contract research, medical, healthcare and pharmaceutical companies, among others. The company has operational presence in France, Switzerland, Netherlands, the UK, the US and Germany, among others. It sells its products through a network of distributors in Germany. Curetis is headquartered in Stuttgart, Baden-Wurttemberg, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Curetis NV

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Curetis NV Company Overview 6

Curetis NV Company Snapshot 6

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview 6

Curetis NV-Pipeline Analysis Overview 9

Curetis NV-Key Facts 9

Curetis NV-Major Products and Services 10

Curetis NV Pipeline Products by Development Stage 11

Curetis NV Ongoing Clinical Trials by Trial Status 14

Curetis NV Pipeline Products Overview 16

Integrated Gyronimo System-CNS Infection 16

Integrated Gyronimo System-CNS Infection Product Overview 16

Integrated Gyronimo System-Infection Control 17

Integrated Gyronimo System-Infection Control Product Overview 17

Integrated Gyronimo System-Viral Testing 18

Integrated Gyronimo System-Viral Testing Product Overview 18

Next Generation Unyvero Implant & Tissue Infections Cartridge 19

Next Generation Unyvero Implant & Tissue Infections Cartridge Product Overview 19

Unyvero Analyzer 20

Unyvero Analyzer Product Overview 20

Unyvero BCU Cartridge 21

Unyvero BCU Cartridge Product Overview 21

Unyvero BCU Cartridge Clinical Trial 22

Unyvero Cardiology Infection Cartridge 23

Unyvero Cardiology Infection Cartridge Product Overview 23

Unyvero CNS Infections Cartridge 24

Unyvero CNS Infections Cartridge Product Overview 24

Unyvero Extended Respiratory Infection Cartridge 25

Unyvero Extended Respiratory Infection Cartridge Product Overview 25

Unyvero i60 Cartridge 26

Unyvero i60 Cartridge Product Overview 26

Unyvero IAI Cartridge 27

Unyvero IAI Cartridge Product Overview 27

Unyvero LRT55 Cartridge-Bronchial Lavage Samples 28

Unyvero LRT55 Cartridge-Bronchial Lavage Samples Product Overview 28

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples 29

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Product Overview 29

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Clinical Trial 30

Unyvero LRT55 Lower Respiratory Tract Cartridge 31

Unyvero LRT55 Lower Respiratory Tract Cartridge Product Overview 31

Unyvero P50 LRT Cartridge 32

Unyvero P50 LRT Cartridge Product Overview 32

Unyvero Pediatric Infections Cartridge 33

Unyvero Pediatric Infections Cartridge Product Overview 33

Unyvero Sepsis Host Response Cartridge 34

Unyvero Sepsis Host Response Cartridge Product Overview 34

Unyvero Tuberculosis Cartridge 35

Unyvero Tuberculosis Cartridge Product Overview 35

Unyvero Urinary Tract Infection Cartridge 36

Unyvero Urinary Tract Infection Cartridge Product Overview 36

Curetis NV-Key Competitors 37

Curetis NV-Key Employees 38

Curetis NV-Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Recent Developments 40

Curetis NV, Recent Developments 40

May 24, 2017: Curetis Provides Business and Financial Update for the First Quarter 2017 40

May 24, 2017: Curetis Provides Update On Unyvero LRT FDA 510(K) Submission 41

Apr 27, 2017: Recent Data on Curetis' Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits 42

Apr 20, 2017: Curetis' Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking 42

Apr 12, 2017: Curetis Expands Supervisory and Medical Advisory Boards 43

Apr 12, 2017: Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance 43

Apr 10, 2017: Curetis to Present Data from Unyvero LRT US FDA Clinical Trial at ASM Microbe 45

Apr 06, 2017: Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing 45

Jan 31, 2017: Curetis' Global Installed Base Expanding to Over 150 Unyvero Analyzers 46

Jan 04, 2017: Curetis Completes Development of Unyvero Cartridge for Intra-Abdominal Infections 47

Appendix 48

Methodology 48

About GlobalData 50

Contact Us 50

Disclaimer 50

List of Figures

Curetis NV Pipeline Products by Equipment Type 7

Curetis NV Pipeline Products by Development Stage 11

Curetis NV Ongoing Clinical Trials by Trial Status 14

List of Tables

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview 6

Curetis NV Pipeline Products by Equipment Type 7

Curetis NV Pipeline Products by Indication 8

Curetis NV Ongoing Clinical Trials by Trial Status 8

Curetis NV, Key Facts 9

Curetis NV, Major Products and Services 10

Curetis NV Number of Pipeline Products by Development Stage 11

Curetis NV Pipeline Products Summary by Development Stage 12

Curetis NV Ongoing Clinical Trials by Trial Status 14

Curetis NV Ongoing Clinical Trials Summary 15

Integrated Gyronimo System-CNS Infection-Product Status 16

Integrated Gyronimo System-CNS Infection-Product Description 16

Integrated Gyronimo System-Infection Control-Product Status 17

Integrated Gyronimo System-Infection Control-Product Description 17

Integrated Gyronimo System-Viral Testing-Product Status 18

Integrated Gyronimo System-Viral Testing-Product Description 18

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Status 19

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Description 19

Unyvero Analyzer-Product Status 20

Unyvero Analyzer-Product Description 20

Unyvero BCU Cartridge-Product Status 21

Unyvero BCU Cartridge-Product Description 21

Unyvero BCU Cartridge-External, Prospective, Multicenter Evaluation Comparing the Performance of the BCU Application Cartridge against the Performance of Conventional Microbiology Work-Up 22

Unyvero Cardiology Infection Cartridge-Product Status 23

Unyvero Cardiology Infection Cartridge-Product Description 23

Unyvero CNS Infections Cartridge-Product Status 24

Unyvero CNS Infections Cartridge-Product Description 24

Unyvero Extended Respiratory Infection Cartridge-Product Status 25

Unyvero Extended Respiratory Infection Cartridge-Product Description 25

Unyvero i60 Cartridge-Product Status 26

Unyvero i60 Cartridge-Product Description 26

Unyvero IAI Cartridge-Product Status 27

Unyvero IAI Cartridge-Product Description 27

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Status 28

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Description 28

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Status 29

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Description 29

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application 30

Unyvero LRT55 Lower Respiratory Tract Cartridge-Product Status 31

Unyvero LRT55 Lower Respiratory Tract Cartridge-Product Description 31

Unyvero P50 LRT Cartridge-Product Status 32

Unyvero P50 LRT Cartridge-Product Description 32

Unyvero Pediatric Infections Cartridge-Product Status 33

Unyvero Pediatric Infections Cartridge-Product Description 33

Unyvero Sepsis Host Response Cartridge-Product Status 34

Unyvero Sepsis Host Response Cartridge-Product Description 34

Unyvero Tuberculosis Cartridge-Product Status 35

Unyvero Tuberculosis Cartridge-Product Description 35

Unyvero Urinary Tract Infection Cartridge-Product Status 36

Unyvero Urinary Tract Infection Cartridge-Product Description 36

Curetis NV, Key Employees 38

Curetis NV, Other Locations 39

Curetis NV, Subsidiaries 39

Glossary 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Curetis NV, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50588
Site License
USD 1500 INR 101175
Corporate User License
USD 2250 INR 151763

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com